Study in Adult Ph-positive ALL

NCT04688983 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia, Adult

Interventions

DRUG: Ponatinib
DRUG: Blinatumomab
DRUG: Imatinib

Sponsor

Cardiff University